Moderna to ask FDA for COVID-19 vaccine authorization
![Moderna Therapeutics...](https://cdn.vox-cdn.com/thumbor/8eGtPYd0HQmA5n8p588TwOECci8=/311x0:3686x2250/1310x873/cdn.vox-cdn.com/uploads/chorus_image/image/68000035/1214038360.jpg.0.jpg)
Moderna plans to file for authorization of its COVID-19 vaccine today, after the final analysis of its clinical trial data confirmed that it is safe and 94 percent effective. It is the second company to submit COVID-19 vaccine data to the Food and Drug Administration, after Pfizer and BioNTech submitted their data earlier this month.
In a press release, Moderna said that there were 196 cases of symptomatic COVID-19 reported in the 30,000-person trial. Of those cases, 185 developed in people who received a placebo, and 11 cases developed in people who took the vaccine. There were 30 cases of severe disease in the trial, and all of them were in the placebo group — indicating that the vaccine can prevent the most dangerous forms of...
Comments
Post a Comment